Clinical Trials
| BMS MINDSET 1 | |
| Therapeutic Area Name | Neurosciences |
| Condition or Disease | Alzheimer's Disease |
| Title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 1) |
| Study ID | BMS MINDSET 1 |
| Principal Investigator First Name | Concetta |
| Principal Investigator Last Name | Forchetti |
| Clinicaltrials.gov | NCT06976216 |